(PRWEB) August 13, 2014
The “Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global Forecast to 2018” report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global molecular biology enzymes, kits & reagents market along with the estimates and forecasts of the revenue and market share analysis.
Browse 133 market data tables, 52 figures spread through 265 pages and in-depth TOC on “Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global Forecast to 2018”
Early buyers will receive 10% customization on this report.
The global molecular biology enzymes, kits & reagents market was valued at $2,847.63 million in 2013. This market is expected to grow at a CAGR of 13.74% to reach $5,420.63 million in 2018.
For More Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=164131709
The molecular biology enzymes, kits & reagents market is segmented on the basis of applications, end users and products. By application, the market is divided into cloning, epigenetics, PCR (Polymerase Chain Reaction), restriction digestion, sequencing, and other applications. Of these, the PCR applications segment accounted for the largest share of the molecular biology enzymes, kits and reagents market in 2013. The end-user segments included in this report are academic research institutes, hospital and diagnostic centers, pharmaceutical and biotech companies, and other end users. By products, the market is segmented into enzymes, and kits and reagents.
The enzymes product segment consists of seven sub-segments, namely, ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptase, and other enzymes. Of these, the polymerase enzyme product sub-segment had the largest share of the molecular biology enzymes market in 2013, and is poised to grow at the highest CAGR between 2013 and 2018. The kits and reagents segment is divided into cloning and mutagenesis, nucleic acid analysis, PCR, sequencing, and other kits and reagents.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=164131709
The geographic segments included in this report are Asia, Europe, North America, and Rest of the World. The Asian segment is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and Rest of Europe. North America includes Canada, and the U.S. The Rest of the World geographic segment encompasses Latin America, Middle East and Africa, and the Pacific region.
Increases in R&D expenditure by pharmaceutical and biotech companies and investments in life science and genomics research will be the two most important growth drivers for this market in the forecast period (2013–2018). For instance, the Chinese government increased its basic research investment by 26% from 2011 to 2012 and put more than $300 billion into biotechnology from 2012 to 2017. Similarly, in 2011, Europe increased investment in research to $108 billion in 2014-2020. This will increase the demand for products offered by the molecular biology enzymes, kits and reagents market. Moreover, the increase in the aged population, at risk of contracting chronic and infectious diseases, will further boost the need for research into ailments such as cancer and heart diseases, further increasing the demand for molecular biology enzymes, kits and reagents products.
The major players in the molecular biology enzymes, kits and reagents market include Affymetrix, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Enzymatics, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs, Inc. (U.S.), QIAGEN, N.V. (Netherlands), Roche, Ltd. (Switzerland), Sigma-Aldrich Co. LLC (U.S), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (U.S.).
Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets